Abstract
No abstract available
Funding Information
  • Tourette Syndrome Association-USA and the Division of Neurology
  • Tourette Syndrome Association
  • Tourette Syndrome Association, NIH-NINDS Loan Repayment Program
  • NIH (NIMH R01 MH078160, NIMH R01 MH08185, NINDS NS056276)
  • Otsuka Pharmaceuticals, Genzyme Corporation, Psyadon Pharmaceuticals Inc.
  • Cincinnati Children’s Hospital Research Foundation, the University of Cincinnati, and the Tourette Syndrome Association

This publication has 24 references indexed in Scilit: